Top-News
Pharmazeutika Schweiz

Obseva SA News

Aktie
WKN:  A3EELW ISIN:  CH1260041939 US-Symbol:  OBSEF
-   $
+0,00 $
0,00%
10.05.24 21:23:36
Handeln Depot/Watchlist
Aktienanzahl *
84,50 Mio.
Marktkapitalisierung *
103,86 Tsd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 29.02.2024

Obseva SA News

20.04.23 - GlobeNewswire
ObsEva Announces Change of Central Securities Depositary
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
31.03.23 - GlobeNewswire
ObsEva Files Year End 2022 Financial Statements
ObsEva Files Year End 2022 Financial Statements
15.03.23 - GlobeNewswire
ObsEva Announces Progress Towards its Plans to Consolidate Operations in Switzerland: Delisting of OBSV from The Nasdaq Stock Market effective March 23, 2023
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
13.03.23 - GlobeNewswire
ObsEva Announces Update Towards its Strategic Reorganization to Consolidate Operations in Switzerland
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
06.03.23 - PR Newswire
Thinking about buying stock in Mullen Automotive, Snap, Meta Platforms, Obseva SA, or Ambrx Biopharma?
Thinking about buying stock in Mullen Automotive, Snap, Meta Platforms, Obseva SA, or Ambrx Biopharma? PR Newswire
24.02.23 - GlobeNewswire
ObsEva Announces Strategic Reorganization to Consolidate Operations in Switzerland
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
19.12.22 - GlobeNewswire
ObsEva Announces Dismissal of Moratorium Proceedings
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
14.12.22 - GlobeNewswire
ObsEva Evidences Compliance with Nasdaq’s Stockholder’s Equity Rule and Announces Moratorium Dismissal Request Filing
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
09.12.22 - GlobeNewswire
ObsEva To Increase Issued Share Capital by Creating Additional Treasury Shares
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
01.12.22 - GlobeNewswire
ObsEva Announces Third Quarter 2022 Financial Results and Provides a Business Update
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
22.11.22 - PR Newswire
Thinking about buying stock in Obseva SA, Cosmos Holdings, Alibaba, American Eagle Outfitters, or TJX Companies?
Thinking about buying stock in Obseva SA, Cosmos Holdings, Alibaba, American Eagle Outfitters, or TJX Companies? PR Newswire
22.11.22 - GlobeNewswire
ObsEva Announces Sale of Ebopiprant License Agreement to XOMA for up to $113 Million
Sale of Ebopiprant royalty and milestone license to XOMA includes upfront payment of $15 million and future milestone payments of up to $98 million The sale proceeds are ...
26.10.22 - GlobeNewswire
ObsEva Announces Progress on Cost Reduction Initiatives and Stay of Moratorium Proceedings
Transition of linzagolix program to Kissei Pharmaceutical Co., Ltd. substantially complete with approximately $ 1 6.0 million savings expected from assignment of program contracts, ...
13.10.22 - GlobeNewswire
ObsEva Announces IND Approval for Yuyuan Bioscience’s Phase 1 Clinical Trial of Nolasiban in China
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
13.09.22 - GlobeNewswire
ObsEva Announces Progress on Restructuring Initiatives
$7.6 million annual savings expected via re duction -in-force currently underway $6.2 million savings expected from assignment of l egacy linzagolix program contracts to Kissei ...
22.08.22 - GlobeNewswire
ObsEva Receives Nasdaq Non-Compliance Notice
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
17.08.22 - GlobeNewswire
ObsEva Files Second Quarter 2022 Financial Statements
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
01.08.22 - GlobeNewswire
ObsEva Announces $31 million Debt Retirement and $11 million Debt Refinancing
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – August 1, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN) , a biopharmaceutical ...
29.07.22 - GlobeNewswire
ObsEva Announces Management Change
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
27.07.22 - PR Newswire
Thinking about buying stock in Shopify, Obseva SA, Vistagen Therapeutics, SIGA Technologies, or Exela Technologies?
Thinking about buying stock in Shopify, Obseva SA, Vistagen Therapeutics, SIGA Technologies, or Exela Technologies? PR Newswire

Newssuche

Videos

newspaper
07.05.24 +6,80%
Technical Trading: DAX Long kurzfristig
DAX Long Typ: Turbo Open End WKN: NG8K9X Hebel: 26 Laufzeit: OpenEnd Einstieg: Market ... Mehr »